News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Neumedicines Inc. To Feature HemaMax Study Results In Presentation At Biotech Showcase Conference



1/9/2014 9:58:37 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Neumedicines Inc., a privately held company developing therapies based on interleukin 12 (IL-12) as a radiation medical countermeasure and as a hematopoietic immunotherapeutic (HIT), today announced that Neumedicines President & CEO Lena A. Basile, Ph.D., J.D., will present at the Biotech Showcase™ conference on Wednesday, January 15, at 11:30 a.m. The conference is being held at the Parc 55 Wyndham hotel in San Francisco.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES